Evidence map›Paper›PMID 29735940›Full record

ArticleInternational journal of molecular sciences2018

New Insight into the Octamer of TYMS Stabilized by Intermolecular Cys43-Disulfide.

Dan Xie, Lulu Wang, Qi Xiao, Xiaoyan Wu, Lin Zhang, Qingkai Yang, Lina Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dan XieInstitute of Cancer Stem Cell, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China. danxie2016@hotmail.com.
Lulu WangSchool of Life Science and Biotechnology, Dalian University of Technology, No. 2 Linggong Road, Dalian 116024, China. wanglulu0813@126.com.
Qi XiaoInstitute of Cancer Stem Cell, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China. xiaoqi1993a@hotmail.com.
Xiaoyan WuInstitute of Cancer Stem Cell, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China. wuxiaoyan1234@hotmail.com.
Lin ZhangInstitute of Cancer Stem Cell, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China. zhanglindlmed@163.com.
Qingkai YangInstitute of Cancer Stem Cell, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China. Qingkaiyang@hotmail.com.
Lina WangInstitute of Cancer Stem Cell, Dalian Medical University, 9 Western Lvshun South Road, Dalian 116044, China. Linawang1109@hotmail.com.ORCID 0000-0002-1162-456X
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymidylate synthase (TYMS) is an essential enzyme for the de novo synthesis of deoxythymidine monophosphate (dTMP) and has been a primary target for cancer chemotherapy. Although the physical structure of TYMS and the molecular mechanisms of TYMS catalyzing the conversion of deoxyuridine monophosphate (dUMP) to dTMP have been the subject of thorough studies, its oligomeric structure remains unclear. Here, we show that human TYMS not only exists in dimer form but also as an octamer by intermolecular Cys43-disulfide formation. We optimized the expression conditions of recombinant human TYMS using the

Indexed as

CysteineDisulfidesEnzyme StabilityHumansKineticsModels, MolecularProtein ConformationProtein MultimerizationThymidylate SynthaseCysteineDisulfidesThymidylate Synthasedimermonomeroctameroverexpression and purificationthymidylate synthase (TYMS)

Identifiers

PMID29735940
PMCPMC5983622
OpenAlexW2800749886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.